Global Insulin API Market Research Report 2023(Status and Outlook)

Global Insulin API Market Research Report 2023(Status and Outlook)



Report Overview

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

The Global Insulin API Market Size was estimated at USD 1692.50 million in 2022 and is projected to reach USD 2067.46 million by 2029, exhibiting a CAGR of 2.90% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Insulin API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insulin API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insulin API market in any manner.

Global Insulin API Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novo Nordisk

Sanofi-Aventis

Eli Lilly

Tonghua Dongbao

Ganlee

United Laboratory

Biocon

Amphastar

Wockhardt

Julphar Diabetes

Torrent Pharma

Market Segmentation (by Type)

Regular Human Insulin

Insulin Analogue

Market Segmentation (by Application)

Large Enterprises

SMEs

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Insulin API Market

Overview of the regional outlook of the Insulin API Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Insulin API
1.2 Key Market Segments
1.2.1 Insulin API Segment by Type
1.2.2 Insulin API Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Insulin API Market Overview
2.1 Global Market Overview
2.1.1 Global Insulin API Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Insulin API Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Insulin API Market Competitive Landscape
3.1 Global Insulin API Sales by Manufacturers (2018-2023)
3.2 Global Insulin API Revenue Market Share by Manufacturers (2018-2023)
3.3 Insulin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insulin API Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Insulin API Sales Sites, Area Served, Product Type
3.6 Insulin API Market Competitive Situation and Trends
3.6.1 Insulin API Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insulin API Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Insulin API Industry Chain Analysis
4.1 Insulin API Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Insulin API Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Insulin API Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insulin API Sales Market Share by Type (2018-2023)
6.3 Global Insulin API Market Size Market Share by Type (2018-2023)
6.4 Global Insulin API Price by Type (2018-2023)
7 Insulin API Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insulin API Market Sales by Application (2018-2023)
7.3 Global Insulin API Market Size (M USD) by Application (2018-2023)
7.4 Global Insulin API Sales Growth Rate by Application (2018-2023)
8 Insulin API Market Segmentation by Region
8.1 Global Insulin API Sales by Region
8.1.1 Global Insulin API Sales by Region
8.1.2 Global Insulin API Sales Market Share by Region
8.2 North America
8.2.1 North America Insulin API Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insulin API Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insulin API Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insulin API Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insulin API Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novo Nordisk
9.1.1 Novo Nordisk Insulin API Basic Information
9.1.2 Novo Nordisk Insulin API Product Overview
9.1.3 Novo Nordisk Insulin API Product Market Performance
9.1.4 Novo Nordisk Business Overview
9.1.5 Novo Nordisk Insulin API SWOT Analysis
9.1.6 Novo Nordisk Recent Developments
9.2 Sanofi-Aventis
9.2.1 Sanofi-Aventis Insulin API Basic Information
9.2.2 Sanofi-Aventis Insulin API Product Overview
9.2.3 Sanofi-Aventis Insulin API Product Market Performance
9.2.4 Sanofi-Aventis Business Overview
9.2.5 Sanofi-Aventis Insulin API SWOT Analysis
9.2.6 Sanofi-Aventis Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Insulin API Basic Information
9.3.2 Eli Lilly Insulin API Product Overview
9.3.3 Eli Lilly Insulin API Product Market Performance
9.3.4 Eli Lilly Business Overview
9.3.5 Eli Lilly Insulin API SWOT Analysis
9.3.6 Eli Lilly Recent Developments
9.4 Tonghua Dongbao
9.4.1 Tonghua Dongbao Insulin API Basic Information
9.4.2 Tonghua Dongbao Insulin API Product Overview
9.4.3 Tonghua Dongbao Insulin API Product Market Performance
9.4.4 Tonghua Dongbao Business Overview
9.4.5 Tonghua Dongbao Insulin API SWOT Analysis
9.4.6 Tonghua Dongbao Recent Developments
9.5 Ganlee
9.5.1 Ganlee Insulin API Basic Information
9.5.2 Ganlee Insulin API Product Overview
9.5.3 Ganlee Insulin API Product Market Performance
9.5.4 Ganlee Business Overview
9.5.5 Ganlee Insulin API SWOT Analysis
9.5.6 Ganlee Recent Developments
9.6 United Laboratory
9.6.1 United Laboratory Insulin API Basic Information
9.6.2 United Laboratory Insulin API Product Overview
9.6.3 United Laboratory Insulin API Product Market Performance
9.6.4 United Laboratory Business Overview
9.6.5 United Laboratory Recent Developments
9.7 Biocon
9.7.1 Biocon Insulin API Basic Information
9.7.2 Biocon Insulin API Product Overview
9.7.3 Biocon Insulin API Product Market Performance
9.7.4 Biocon Business Overview
9.7.5 Biocon Recent Developments
9.8 Amphastar
9.8.1 Amphastar Insulin API Basic Information
9.8.2 Amphastar Insulin API Product Overview
9.8.3 Amphastar Insulin API Product Market Performance
9.8.4 Amphastar Business Overview
9.8.5 Amphastar Recent Developments
9.9 Wockhardt
9.9.1 Wockhardt Insulin API Basic Information
9.9.2 Wockhardt Insulin API Product Overview
9.9.3 Wockhardt Insulin API Product Market Performance
9.9.4 Wockhardt Business Overview
9.9.5 Wockhardt Recent Developments
9.10 Julphar Diabetes
9.10.1 Julphar Diabetes Insulin API Basic Information
9.10.2 Julphar Diabetes Insulin API Product Overview
9.10.3 Julphar Diabetes Insulin API Product Market Performance
9.10.4 Julphar Diabetes Business Overview
9.10.5 Julphar Diabetes Recent Developments
9.11 Torrent Pharma
9.11.1 Torrent Pharma Insulin API Basic Information
9.11.2 Torrent Pharma Insulin API Product Overview
9.11.3 Torrent Pharma Insulin API Product Market Performance
9.11.4 Torrent Pharma Business Overview
9.11.5 Torrent Pharma Recent Developments
10 Insulin API Market Forecast by Region
10.1 Global Insulin API Market Size Forecast
10.2 Global Insulin API Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Insulin API Market Size Forecast by Country
10.2.3 Asia Pacific Insulin API Market Size Forecast by Region
10.2.4 South America Insulin API Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Insulin API by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Insulin API Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Insulin API by Type (2024-2029)
11.1.2 Global Insulin API Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Insulin API by Type (2024-2029)
11.2 Global Insulin API Market Forecast by Application (2024-2029)
11.2.1 Global Insulin API Sales (K MT) Forecast by Application
11.2.2 Global Insulin API Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings